May 3, 2022
D.C. News
  • A new Republican plan to lower drug costs abandons direct government negotiations and other signature policies from the Trump years. The plan would create an out-of-pocket cap on drug spending for seniors and people with disabilities, ensure patients pay the same rate for physician-administered drugs in a doctor’s office and for medicines provided in a hospital department, and prohibit “pay for delay” pharmaceutical deals. It does not include direct negotiations or using prices paid by other countries to cap what the U.S. will pay for a drug. (Plan here)